Probiome Therapeutics Inc. is working towards developing innovative probiotics targeting to improve the health of patients with severe chronic diseases including neurodegenerative diseases. Probiome’s innovative probiotics are programmed to deliver specially designed therapeutics for treatment of several neurological diseases including Parkinson’s and Alzheimer’s as well as mood disorders such as depression and anxiety.
Probiome Therapeutics is a privately held company with corporate values. We strive for excellence, high level of productivity, conduct with integrity and high ethical standards. We respect the intellectual and team experience of our colleagues. We value diversity, positive attitude and nurturing work environment.
Anumantha G. Kanthasamy, PhD, Founder & CEO
2314 Sundown Drive
Ames, IA 50014